missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tenascin C Monoclonal Antibody (4C8MS), Invitrogen™
Mouse Monoclonal Antibody
Marque: Invitrogen MA516086
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Tenascin is a high molecular weight, multifunctional, extracellular matrix glycoprotein expressed in association with mesenchymal-epithelial interactions during development and in the neovasculature and stroma of undifferentiated tumors (Erickson and Bourdon 1989). It has been described under a variety of names: cytotactin, hexabrachion protein, J1, myotendinous antigen (MI) and glioma mesenchymal extracellular matrix (GMEM). The tenascin molecule is a disulfide-linked hexamer. The expression of tenascin is associated with development and growth, both normal and pathological, whereas the distribution in normal adult tissue is restricted.
Spécification
| Tenascin C | |
| Monoclonal | |
| 1.0 mg/mL | |
| PBS with 0.02% sodium azide | |
| P24821, Q80YX1 | |
| TNC | |
| Recombinant human Tenascin C. | |
| 100 μL | |
| Primary | |
| Feline, Human, Mouse, Rat | |
| Antibody | |
| IgG1 |
| ELISA, Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Western Blot | |
| 4C8MS | |
| Unconjugated | |
| TNC | |
| 150-225; AI528729; C130033P17Rik; cytotactin; deafness, autosomal dominant 56; DFNA56; Glioma-associated-extracellular matrix antigen; GMEM; GP; GP 150-225; hexabrachion; hexabrachion (tenascin); Hxb; JI; MGC144208; MGC144209; MGC167029; Myotendinous antigen; neuronectin; Ten; Tenascin; tenascin C; Tenascin-C; tenascin-C additional domain 1; tenascin-C isoform 14/AD1/16; TN; tnc; TN-C | |
| Mouse | |
| Protein A | |
| RUO | |
| 101083629, 116640, 21923, 3371 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu